Related references
Note: Only part of the references are listed.Improvements in pain, medication use and quality of life in onabotulinumtoxinA-resistant chronic migraine patients following erenumab treatment - real world outcomes
J. Talbot et al.
JOURNAL OF HEADACHE AND PAIN (2021)
Effects of open-label placebos on test performance and psychological well-being in healthy medical students: a randomized controlled trial
Julian Kleine-Borgmann et al.
SCIENTIFIC REPORTS (2021)
Neurotransmitter systems involved in placebo and nocebo effects in healthy participants and patients with chronic pain: a systematic review
Ina Skyt et al.
PAIN (2020)
Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)
Messoud Ashina et al.
CEPHALALGIA (2020)
Open-label placebo treatment of women with premenstrual syndrome: study protocol of a randomised controlled trial
Antje Frey Nascimento et al.
BMJ OPEN (2020)
Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2
Richard B. Lipton et al.
NEUROLOGY (2020)
TractoFlow: A robust, efficient and reproducible diffusion MRI pipeline leveraging Nextflow & Singularity
Guillaume Theaud et al.
NEUROIMAGE (2020)
Development of the generic, multidimensional Treatment Expectation Questionnaire (TEX-Q) through systematic literature review, expert surveys and qualitative interviews
Jannis Alberts et al.
BMJ OPEN (2020)
White matter tract microstructure of the mPFC-amygdala predicts interindividual differences in placebo response related to treatment in migraine patients
Jixin Liu et al.
HUMAN BRAIN MAPPING (2019)
Patient selection for migraine preventive treatment with anti-CGRP(r) monoclonal antibodies
Andrea Negro et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2019)
Aberrant interactions of cortical networks in chronic migraine A resting-state fMRI study
Gianluca Coppola et al.
NEUROLOGY (2019)
The human stress response
Georgina Russell et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
Effects of open-label placebo on pain, functional disability, and spine mobility in patients with chronic back pain: a randomized controlled trial
Julian Kleine-Borgmann et al.
PAIN (2019)
fMRIPrep: a robust preprocessing pipeline for functional MRI
Oscar Esteban et al.
NATURE METHODS (2019)
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults
Cristina Tassorelli et al.
CEPHALALGIA (2018)
Open-Label Placebo Treatment for Cancer-Related Fatigue: A Randomized-Controlled Clinical Trial
Teri W. Hoenemeyer et al.
SCIENTIFIC REPORTS (2018)
Cost-effectiveness analysis of erenumab for the preventive treatment of episodic and chronic migraine: Results from the US societal and payer perspectives
Matthew Sussman et al.
CEPHALALGIA (2018)
Open label placebo: can honestly prescribed placebos evoke meaningful therapeutic benefits?
Ted J. Kaptchuk et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
OPEN-LABEL PLACEBO reflections on a research agenda
Ted J. Kaptchuk
PERSPECTIVES IN BIOLOGY AND MEDICINE (2018)
Integration of White Matter Network Is Associated with Interindividual Differences in Psychologically Mediated Placebo Response in Migraine Patients
Jixin Liu et al.
HUMAN BRAIN MAPPING (2017)
The Fear of Pain Questionnaire-III and the Fear of Pain Questionnaire-Short Form: a confirmatory factor analysis
Sara M. Vambheim et al.
JOURNAL OF PAIN RESEARCH (2017)
The German version of the Perceived Stress Scale - psychometric characteristics in a representative German community sample
Eva M. Klein et al.
BMC PSYCHIATRY (2016)
STATE-DEPENDENT VARIABILITY OF DYNAMIC FUNCTIONAL CONNECTIVITY BETWEEN FRONTOPARIETAL AND DEFAULT NETWORKS RELATES TO COGNITIVE FLEXIBILITY
Linda Douw et al.
NEUROSCIENCE (2016)
Open-label placebo treatment in chronic low back pain: a randomized controlled trial
Claudia Carvalho et al.
PAIN (2016)
Assessment of the cortisol awakening response: Expert consensus guidelines
Tobias Stalder et al.
PSYCHONEUROENDOCRINOLOGY (2016)
Comment: The FAIR Guiding Principles for scientific data management and stewardship
Mark D. Wilkinson et al.
SCIENTIFIC DATA (2016)
Is somatosensory amplification a risk factor for an increased report of side effects? Reference data from the German general population
B. K. Doering et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2015)
Genetics and the placebo effect: the placebome
Kathryn T. Hall et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Catechol-O-Methyltransferase Val158Met Polymorphism Is Associated with Somatosensory Amplification and Nocebo Responses
Laura Wendt et al.
PLOS ONE (2014)
Altered Placebo and Drug Labeling Changes the Outcome of Episodic Migraine Attacks
Slavenka Kam-Hansen et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Prediction of placebo responses: a systematic review of the literature
Bjoern Horing et al.
FRONTIERS IN PSYCHOLOGY (2014)
Individual and Gender Differences in Subjective and Objective Indices of Pain: Gender, Fear of Pain, Pain Catastrophizing and Cardiovascular Reactivity
Joseph Etherton et al.
APPLIED PSYCHOPHYSIOLOGY AND BIOFEEDBACK (2014)
The Role of Positive Traits and Pain Catastrophizing in Pain Perception
Kim Pulvers et al.
CURRENT PAIN AND HEADACHE REPORTS (2013)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
OPINION The placebo response in medicine: minimize, maximize or personalize?
Paul Enck et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Migraine and structural changes in the brain A systematic review and meta-analysis
Asma Bashir et al.
NEUROLOGY (2013)
Plasma Noradrenaline and State Anxiety Levels Predict Placebo Response in Learned Immunosuppression
K. Ober et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia
Niklas Stein et al.
PAIN (2012)
Catechol-O-Methyltransferase val158met Polymorphism Predicts Placebo Effect in Irritable Bowel Syndrome
Kathryn T. Hall et al.
PLOS ONE (2012)
Assessing general side effects in clinical trials: reference data from the general population
Winfried Rief et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
The relation of emotions to placebo responses
Magne Arve Flaten et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2011)
Migraine treatment and placebo effect
Jose G. Speciali et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Serum correlates of the placebo effect in irritable bowel syndrome
E. Kokkotou et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran
Michael E. Geisser et al.
PAIN (2010)
Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
Ted J. Kaptchuk et al.
PLOS ONE (2010)
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses
David J. Scott et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Do placebo responders exist?
Ted J. Kaptchuk et al.
CONTEMPORARY CLINICAL TRIALS (2008)
Open-label use of placebos in the treatment of ADHD: a pilot study
A. D. Sandler et al.
CHILD CARE HEALTH AND DEVELOPMENT (2008)
The impact of topiramate on health-related quality of life indicators in chronic migraine
David W. Dodick et al.
HEADACHE (2007)
G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
Franz Faul et al.
BEHAVIOR RESEARCH METHODS (2007)
Measuring personality in one minute or less: A 10-item short version of the Big Five Inventory in English and German
Beatrice Rammstedt et al.
JOURNAL OF RESEARCH IN PERSONALITY (2007)
Migraine prevalence, disease burden, and the need for preventive therapy
R. B. Lipton et al.
NEUROLOGY (2007)
A six-item short-form survey for measuring headache impact: The HIT-6 (TM)
M Kosinski et al.
QUALITY OF LIFE RESEARCH (2003)
Migraine medication attributes important for patient compliance: Concerns about side effects may delay treatment
RM Gallagher et al.
HEADACHE (2003)
Share Paper
